For the global eradication of Rh disease, our international consortium of physicians, scientists, epidemiologists, midwives, global health advocates, and industrial partners is committed to “doing something” by initiating a series of pilot projects in underserved settings to help families now, and to demonstrate proof-of-principle approaches that can be scaled up in the future to serve large populations. To this end, Columbia University, on November 1, 2018, will be hosting a full-day symposium during which a roster of prominent speakers from around the world, representing multiple medical specialties and points of view, will discuss these issues.
In addition, Dr. Peter Agre, the Bloomberg Distinguished Professor at the Johns Hopkins Bloomberg School of Public Health, will present the 3rd Annual John Gorman Lectureship in Transfusion Medicine as part of the symposium. Although Dr. Agre won the Nobel Prize for his work on aquaporin, he also was one of the individuals who first cloned and sequenced the Rh gene. The title of his lecture is: “Aquaporin water channels – from Rh to Malaria”
